Fortuna Health

-62%

est. 2Y upside i

HealthcareSeries A

At Fortuna Health, we’re rebuilding the consumer experience Medicaid. We believe that fixing the front door to public health benefits is one of the most urgent product challenges of our time - and that great design and infrastructure can unlock access, efficiency, and autonomy for millions.

Rank

#639

Sector

Health Technology

Est. Liquidity

~6Y

Data Quality

Data: Medium

Fortuna Health presents a moderate upside opportunity driven by its innovative, AI-powered platform addressing the complex and growing need for streamlined Medicaid eligibility and enrollment.

Last updated: March 10, 2026

Bull (30%)+300%

Fortuna Health successfully leverages its AI-powered platform to rapidly expand into new states and deepen integrations with major health plans and providers, becoming the dominant 'TurboTax for Medicaid' solution. This leads to significant revenue growth, exceeding $150M ARR by 2028, and justifies a $488M+ valuation (4x current) through an acquisition or successful IPO, driven by its critical role in navigating complex federal reforms.

Base (40%)+100%

Fortuna Health achieves steady growth by solidifying its market position in several key states and expanding partnerships with health systems and managed care organizations. While facing ongoing challenges in regulatory adaptation and competition, the company reaches approximately $75M ARR by 2028, leading to a $244M valuation (2x current) at a liquidity event, reflecting its established niche in Medicaid navigation.

Bear (30%)-80%

Slower-than-expected adoption by states and health plans, coupled with new, unfavorable regulatory changes or a dominant incumbent (like Deloitte) launching a directly competing, well-resourced solution, significantly hampers Fortuna's growth. Revenue stalls below $30M ARR, leading to a down round or acquisition at a distressed valuation of $24M, wiping out most common stock value given the $23M in liquidation preferences.

Est. time to liquidity~6.0 years

Preference Stack Risk

high

Funding Intensity

19%

Investors hold $23M in liquidation preferences ahead of common shareholders, representing 18.85% of the current $122M valuation.

Dilution Risk

high

As a Series A company, Fortuna Health will likely undergo several more funding rounds, leading to significant future dilution for current equity holders.

Secondary Liquidity

none

Given its early stage (Series A), there is currently no active secondary market for Fortuna Health shares.

Questions to Ask at the Interview

Strategic questions based on Fortuna Health's data — designed to show you've done your homework.

1
“Given the complexity of 56 different Medicaid programs, how is Fortuna Health prioritizing state expansion, and what are the biggest challenges in integrating with new state systems?”
2
“With Medicaid enrollment expected to flatten in FY 2026, how does Fortuna Health plan to drive continued revenue growth and market penetration beyond initial enrollment surges?”
3
“Considering the $23M in total funding on a $122M valuation, how does the company envision future funding rounds impacting employee equity, and what is the anticipated timeline for a liquidity event?”

Community

Valuation Sentiment

Our model estimates -62% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.